{"id":4907,"date":"2026-06-27T17:57:11","date_gmt":"2026-06-27T17:57:11","guid":{"rendered":"https:\/\/www.insuracarelife.com\/blog\/cancer-claims-and-specialty-drugs-drive-stop-loss-cost-surge-qbe\/"},"modified":"2026-06-27T17:57:11","modified_gmt":"2026-06-27T17:57:11","slug":"cancer-claims-and-specialty-drugs-drive-stop-loss-cost-surge-qbe","status":"publish","type":"post","link":"https:\/\/www.insuracarelife.com\/blog\/cancer-claims-and-specialty-drugs-drive-stop-loss-cost-surge-qbe\/","title":{"rendered":"Cancer claims and specialty drugs drive stop-loss cost surge: QBE"},"content":{"rendered":"<div>\n<p>The annual report, which draws on QBE&#8217;s proprietary claims data, found that neoplasms account for 36% of all stop-loss claim reimbursements, maintaining their position as the leading diagnosis across all deductible levels. At the $200,000 deductible level, neoplasm claim severity rose 12% from the average of prior years, while frequency climbed nearly 30%. Across all conditions, the frequency of members exceeding $200,000 in annual claims per 10,000 employees increased by nearly 20% year on year, driven primarily by neoplasms, birth-related claims and circulatory diseases. Birth-related claim frequency more than doubled between 2024 and 2025.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The annual report, which draws on QBE&#8217;s proprietary claims data, found that neoplasms account for 36% of all stop-loss claim reimbursements, maintaining their position as the leading diagnosis across all deductible levels. At the $200,000 deductible level, neoplasm claim severity rose 12% from the average of prior years, while frequency climbed nearly 30%. Across all [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4908,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3908,263,790,3909,420,2541,1309,3910,1706],"class_list":["post-4907","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-cancer","tag-claims","tag-cost","tag-drive","tag-drugs","tag-qbe","tag-specialty","tag-stoploss","tag-surge"],"_links":{"self":[{"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/posts\/4907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/comments?post=4907"}],"version-history":[{"count":0,"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/posts\/4907\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/media\/4908"}],"wp:attachment":[{"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/media?parent=4907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/categories?post=4907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insuracarelife.com\/blog\/wp-json\/wp\/v2\/tags?post=4907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}